Bank of America’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Sell |
25,633
-5,651
| -18% | -$35.4K | ﹤0.01% | 5326 |
|
|
2025
Q1 | $183K | Sell |
31,284
-20,002
| -39% | -$117K | ﹤0.01% | 5255 |
|
|
2024
Q4 | $422K | Buy |
51,286
+8,709
| +20% | +$71.6K | ﹤0.01% | 4841 |
|
|
2024
Q3 | $379K | Buy |
42,577
+5,582
| +15% | +$49.7K | ﹤0.01% | 4827 |
|
|
2024
Q2 | $280K | Buy |
36,995
+2,062
| +6% | +$15.6K | ﹤0.01% | 4912 |
|
|
2024
Q1 | $274K | Sell |
34,933
-527
| -1% | -$4.14K | ﹤0.01% | 4890 |
|
|
2023
Q4 | $314K | Sell |
35,460
-5,563
| -14% | -$49.3K | ﹤0.01% | 4918 |
|
|
2023
Q3 | $368K | Sell |
41,023
-2,782
| -6% | -$25K | ﹤0.01% | 4684 |
|
|
2023
Q2 | $541K | Buy |
43,805
+2,712
| +7% | +$33.5K | ﹤0.01% | 4443 |
|
|
2023
Q1 | $381K | Buy |
41,093
+13,878
| +51% | +$129K | ﹤0.01% | 4792 |
|
|
2022
Q4 | $286K | Sell |
27,215
-18,024
| -40% | -$189K | ﹤0.01% | 5010 |
|
|
2022
Q3 | $820K | Buy |
45,239
+9,896
| +28% | +$179K | ﹤0.01% | 4323 |
|
|
2022
Q2 | $501K | Buy |
35,343
+23,486
| +198% | +$333K | ﹤0.01% | 4732 |
|
|
2022
Q1 | $261K | Buy |
11,857
+4,131
| +53% | +$90.9K | ﹤0.01% | 5549 |
|
|
2021
Q4 | $131K | Buy |
+7,726
| New | +$131K | ﹤0.01% | 5917 |
|